Literature DB >> 24424124

Clinical utility gene card for: Phosphomannomutase 2 deficiency.

Jaak Jaeken1, Dirk Lefeber2, Gert Matthijs3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24424124      PMCID: PMC4350603          DOI: 10.1038/ejhg.2013.298

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


× No keyword cloud information.
  14 in total

1.  Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia).

Authors:  E Schollen; S Kjaergaard; E Legius; M Schwartz; G Matthijs
Journal:  Eur J Hum Genet       Date:  2000-05       Impact factor: 4.246

2.  The molecular landscape of phosphomannose mutase deficiency in iberian peninsula: identification of 15 population-specific mutations.

Authors:  B Pérez; P Briones; D Quelhas; R Artuch; A I Vega; E Quintana; L Gort; M J Ecay; G Matthijs; M Ugarte; C Pérez-Cerdá
Journal:  JIMD Rep       Date:  2011-06-22

3.  Effect of mutations found in carbohydrate-deficient glycoprotein syndrome type IA on the activity of phosphomannomutase 2.

Authors:  M Pirard; G Matthijs; L Heykants; E Schollen; S Grünewald; J Jaeken; E van Schaftingen
Journal:  FEBS Lett       Date:  1999-06-11       Impact factor: 4.124

4.  Lack of homozygotes for the most frequent disease allele in carbohydrate-deficient glycoprotein syndrome type 1A.

Authors:  G Matthijs; E Schollen; E Van Schaftingen; J J Cassiman; J Jaeken
Journal:  Am J Hum Genet       Date:  1998-03       Impact factor: 11.025

5.  Increased recurrence risk in congenital disorders of glycosylation type Ia (CDG-Ia) due to a transmission ratio distortion.

Authors:  E Schollen; S Kjaergaard; T Martinsson; S Vuillaumier-Barrot; M Dunoe; L Keldermans; N Seta; G Matthijs
Journal:  J Med Genet       Date:  2004-11       Impact factor: 6.318

Review 6.  The clinical spectrum of phosphomannomutase 2 deficiency (CDG-Ia).

Authors:  Stephanie Grünewald
Journal:  Biochim Biophys Acta       Date:  2009-01-14

Review 7.  Congenital disorders of glycosylation: an update on defects affecting the biosynthesis of dolichol-linked oligosaccharides.

Authors:  Micha A Haeuptle; Thierry Hennet
Journal:  Hum Mutat       Date:  2009-12       Impact factor: 4.878

8.  Absence of homozygosity for predominant mutations in PMM2 in Danish patients with carbohydrate-deficient glycoprotein syndrome type 1.

Authors:  S Kjaergaard; F Skovby; M Schwartz
Journal:  Eur J Hum Genet       Date:  1998 Jul-Aug       Impact factor: 4.246

9.  Prenatal diagnosis in CDG1 families: beware of heterogeneity.

Authors:  G Matthijs; E Schollen; J J Cassiman; V Cormier-Daire; J Jaeken; E van Schaftingen
Journal:  Eur J Hum Genet       Date:  1998 Mar-Apr       Impact factor: 4.246

10.  Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I.

Authors:  E Van Schaftingen; J Jaeken
Journal:  FEBS Lett       Date:  1995-12-27       Impact factor: 4.124

View more
  1 in total

1.  In Vitro Fertilisation (IVF) Associated with Preimplantation Genetic Testing for Monogenic Diseases (PGT-M) in a Romanian Carrier Couple for Congenital Disorder of Glycosylation Type Ia (CDG-Ia): A Case Report.

Authors:  Bogdan Doroftei; Loredana Nemtanu; Ovidiu-Dumitru Ilie; Gabriela Simionescu; Iuliu Ivanov; Emil Anton; Maria Puiu; Radu Maftei
Journal:  Genes (Basel)       Date:  2020-06-25       Impact factor: 4.096

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.